Obesity management in adults: a review
A Elmaleh-Sachs, JL Schwartz, CT Bramante… - Jama, 2023 - jamanetwork.com
Importance Obesity affects approximately 42% of US adults and is associated with increased
rates of type 2 diabetes, hypertension, cardiovascular disease, sleep disorders …
rates of type 2 diabetes, hypertension, cardiovascular disease, sleep disorders …
[HTML][HTML] Excess body weight: Novel insights into its roles in obesity comorbidities
Excess body weight is a global health problem due to sedentary lifestyle and unhealthy diet,
affecting 2 billion population worldwide. Obesity is a major risk factor for metabolic diseases …
affecting 2 billion population worldwide. Obesity is a major risk factor for metabolic diseases …
Tirzepatide once weekly for the treatment of obesity
AM Jastreboff, LJ Aronne, NN Ahmad… - … England Journal of …, 2022 - Mass Medical Soc
Background Obesity is a chronic disease that results in substantial global morbidity and
mortality. The efficacy and safety of tirzepatide, a novel glucose-dependent insulinotropic …
mortality. The efficacy and safety of tirzepatide, a novel glucose-dependent insulinotropic …
Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 …
Importance Weight loss improves cardiometabolic risk factors in people with overweight or
obesity. Intensive lifestyle intervention and pharmacotherapy are the most effective …
obesity. Intensive lifestyle intervention and pharmacotherapy are the most effective …
Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures–2019 update: cosponsored …
JI Mechanick, C Apovian, S Brethauer… - Surgery for Obesity and …, 2020 - Elsevier
Objective The development of these updated clinical practice guidelines (CPG) was
commissioned by the American Association of Clinical Endocrinologists, The Obesity …
commissioned by the American Association of Clinical Endocrinologists, The Obesity …
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2· 4 mg for weight …
Background Cagrilintide, a long-acting amylin analogue, and semaglutide 2· 4 mg, a
glucagon-like peptide-1 analogue, are both being investigated as options for weight …
glucagon-like peptide-1 analogue, are both being investigated as options for weight …
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active …
Background LY3298176 is a novel dual glucose-dependent insulinotropic polypeptide (GIP)
and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the …
and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the …
Changing the global obesity narrative to recognize and reduce weight stigma: a position statement from the World Obesity Federation
Weight stigma, defined as pervasive misconceptions and stereotypes associated with higher
body weight, is both a social determinant of health and a human rights issue. It is imperative …
body weight, is both a social determinant of health and a human rights issue. It is imperative …
Effects of 8-hour time restricted feeding on body weight and metabolic disease risk factors in obese adults: A pilot study
K Gabel, KK Hoddy, N Haggerty, J Song… - … and healthy aging, 2018 - content.iospress.com
BACKGROUND: Time restricted feeding decreases energy intake without calorie counting
and may be a viable option for weight loss. However, the effect of this diet on body weight in …
and may be a viable option for weight loss. However, the effect of this diet on body weight in …
AGA clinical practice guideline on pharmacological interventions for adults with obesity
Background & Aims Pharmacological management of obesity improves outcomes and
decreases the risk of obesity-related complications. This American Gastroenterological …
decreases the risk of obesity-related complications. This American Gastroenterological …